Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels
COVID-19 住院病例中关键 B 细胞活化标志物 HLA-DR 水平较低与疾病严重程度、地塞米松治疗和循环 IL-6 水平有关
期刊:Immunologic Research
影响因子:3.3
doi:10.1007/s12026-022-09269-w
Anthony Dobi, Arthur Dubernet, Mahary Lalarizo Rakoto, Anne-Laure Sandenon Seteyen, Damien Vagner, Grégorie Lebeau, Loïc Raffray, Philippe Gasque